Kane Biotech Inc. (the 'company') announced that it has entered into an amending agreement with Pivot Financial I Limited Partnership (Pivot') to the amended and restated credit agreement between the Company and Pivot dated August 31, 2021, extending the maturity date of its credit facility from January 31, 2023 to February 28, 2023. Kane and Pivot are working towards finalizing a longer term extension to the credit facility and this extension provides time for that to be completed.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.13 CAD | +4.00% | -7.14% | +62.50% |
04-18 | Transcript : Kane Biotech Inc. - Special Call | |
04-15 | Kane Biotech Up 12% After Reporting Closing of STEM Animal Health Sale | MT |
1st Jan change | Capi. | |
---|---|---|
+62.50% | 12.56M | |
+1.77% | 42.86B | |
+45.15% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- KNE Stock
- News Kane Biotech Inc.
- Kane Biotech Announces Extension of Term of Credit Facility